source
- Only one third of US prostate cancer patients received pre-biopsy MRI in 2022, far below Western normsMRI is considered the standard pre-biopsy imaging tool for prostate cancer in most western nations, yet a new analysis shows that only about a third of US cases used it in 2022. In the United Stat…
- Excluding orphan drugs from Medicare pricing pilots could erase most savings, analysis showsA Harvard researcher has calculated that removing rare disease treatments from two Medicare pilot programs-GLOBE and GUARD-would dramatically cut the projected cost savings. The pilots are designe…